Every effective cancer treatment plan begins with an accurate diagnosis and a precise understanding of how far the disease has spread. Getting this right — the tumour type, its biological characteristics, and its exact stage — shapes every decision that follows, from whether surgery is appropriate, to what sequence of treatments offers the best outcome. Rushing or shortcutting this step risks a treatment plan built on an incomplete picture.

The diagnostic pathway typically begins with detailed clinical assessment and imaging — CT, MRI, PET, or ultrasound depending on the suspected cancer type — to identify and characterise the area of concern. Tissue diagnosis follows, obtained through image-guided, endoscopic, or surgical biopsy, and is then examined in detail by pathology, often including molecular and genetic profiling that can influence treatment selection. Together, these findings are mapped against established staging systems — most commonly the TNM system — to define the cancer’s exact stage, a critical factor in prognosis and treatment planning.

Because accurate staging often draws on multiple specialties, every case is reviewed within a multidisciplinary tumour board — radiology, pathology, surgical oncology, medical oncology, and radiation oncology working together to confirm the diagnosis, agree on the stage, and shape a coordinated treatment recommendation before any therapy begins.